Abiopharma

Clinical trial NCT07640295 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-22 → 2026-07-16

Clinical trial NCT07224022 updates: 1. start date: 2026-07-01 → 2026-10-01 2. completion date: 2029-11-30 → 2029-06-30 3. primary completion date: 2028-08-31 → 2028-12-31

Clinical trial NCT05904106 updates: 1. completion date: 2028-09-01 → 2030-09-01 2. primary completion date: 2028-09-01 → 2030-09-01

Clinical trial NCT07671677 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-01 → 2026-08-13

Clinical trial NCT06993142 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-07-01 → 2025-09-01

Clinical trial NCT07712874: start date: 2026-08-31 → 2026-09-01.

Clinical trial NCT05150691: primary completion date: 2026-04-01 → 2027-08-01.

Clinical trial NCT07298863 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-04-30 → 2026-09-01 3. primary completion date: 2026-04-01 → 2026-09-01 4. enrollment: 74 → 104 participants 5. collaborators added: PeakGenics Innovation Inc.

Clinical trial NCT07709000: start date: 2026-08-21 → 2026-09-11.

Clinical trial NCT06525389 updates: 1. start date: 2026-07-01 → 2026-09-01 2. completion date: 2031-07-01 → 2031-09-01 3. primary completion date: 2030-07-01 → 2030-09-01

Clinical trial NCT06233461: primary completion date: 2026-09-18 → 2027-02-17.

Clinical trial NCT07071961: status: SUSPENDED → RECRUITING.

Clinical trial NCT04962061 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-31 → 2026-03-03 3. primary completion date: 2025-12-31 → 2026-02-06 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07652359: start date: 2026-07-14 → 2026-08-26.

Clinical trial NCT05952258: enrollment: 158 → 220 participants.